Circulating proteins in response to combined-modality therapy in rectal cancer identified by antibody array screening

BACKGROUND: The increasingly complex programs of contemporary cancer therapy emphasize the need for biological indicators of both therapeutic response and adverse effects. One example is combined-modality treatment aimed at improving long-term outcome in patients with locally advanced rectal cancer,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalanxhi, Erta, Hektoen, Helga Helseth, Meltzer, Sebastian, Dueland, Svein, Flatmark, Kjersti, Ree, Anne Hansen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962367/
https://www.ncbi.nlm.nih.gov/pubmed/27461255
http://dx.doi.org/10.1186/s12885-016-2601-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962367/
https://www.ncbi.nlm.nih.gov/pubmed/27461255
http://dx.doi.org/10.1186/s12885-016-2601-x

Ejemplares similares